title: Effect of prenatal restraint stress and morphine co-administration on plasma vasopressin concentration and anxiety behaviors in adult rat offspring.
abstract: Stressful events and exposure to opiates during gestation have important effects on the later mental health of the offspring. Anxiety is among the most common mental disorders. The present study aimed to identify effects of prenatal restraint stress and morphine co-administration on plasma vasopressin concentration (PVC) and anxiety behaviors in rats. Pregnant rats were divided into four groups (n = 6, each): saline, morphine, stress + saline and stress + morphine treatment. The stress procedure consisted of restraint twice per day, two hours per session, for three consecutive days starting on day 15 of pregnancy. Rats in the saline and morphine groups received either 0.9% saline or morphine intraperitoneally on the same days. In the morphine/saline + stress groups, rats were exposed to restraint stress and received either morphine or saline intraperitoneally. All offspring were tested in an elevated plus maze (EPM) on postnatal day 90 (n = 6, each sex), and anxiety behaviors of each rat were recorded. Finally, blood samples were collected to determine PVC. Prenatal morphine exposure reduced anxiety-like behaviors. Co-administration of prenatal stress and morphine increased locomotor activity (LA) and PVC. PVC was significantly lower in female offspring of the morphine and morphine + stress groups compared with males in the same group, but the opposite was seen in the saline + stress group. These data emphasize the impact of prenatal stress and morphine on fetal neuroendocrine development, with long-term changes in anxiety-like behaviors and vasopressin secretion. These changes are sex specific, indicating differential impact of prenatal stress and morphine on fetal neuroendocrine system development. Lay Summary Pregnant women are sometimes exposed to stressful and painful conditions which may lead to poor outcomes for offspring. Opiates may provide pain and stress relief to these mothers. In this study, we used an experimental model of maternal exposure to stress and morphine in pregnant rats. The findings indicated that maternal stress increased anxiety in offspring while morphine decreased such effects, but had negative effects on the levels of a hormone controlling blood pressure, and activity of offspring. Hence morphine should not be used in pregnancy for pain and stress relief.
authors.affiliation: a Studental Research Committee , Urmia University of Medical Sciences , Urmia , Iran.
authors.forename: Elnaz
authors.initials: E
authors.lastname: Nakhjiri
authors.affiliation: b Neurophysiology Research Center, Urmia University of Medical Sciences , Urmia , Iran.
authors.forename: Ehsan
authors.initials: E
authors.lastname: Saboory
authors.affiliation: c Department of Physiology, Faculty of Medicine , Urmia University of Medical Sciences , Urmia , Iran.
authors.forename: Shiva
authors.initials: S
authors.lastname: Roshan-Milani
authors.affiliation: d Cellular and Molecular Research Center, Urmia University of Medical Sciences , Urmia , Iran.
authors.forename: Yousef
authors.initials: Y
authors.lastname: Rasmi
authors.affiliation: d Cellular and Molecular Research Center, Urmia University of Medical Sciences , Urmia , Iran.
authors.forename: Davod
authors.initials: D
authors.lastname: Khalafkhani
mesh_terms: D000818:Animals; D001007:Anxiety / Q000097:blood / Q000503:physiopathology*; D001522:Behavior, Animal / Q000502:physiology; D005260:Female; D008297:Male; D009020:Morphine / Q000494:pharmacology*; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects / Q000097:blood / Q000503:physiopathology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012149:Restraint, Physical; D013312:Stress, Physiological / Q000502:physiology*; D013315:Stress, Psychological / Q000097:blood / Q000503:physiopathology*; D014667:Vasopressins / Q000097:blood*
chemical_list: D014667:Vasopressins; D009020:Morphine
keywords: Anxiety; elevated plus maze; morphine; restraint stress; sex differences; vasopressin